Metropolitan Life Insurance Company (MetLife)’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,114
| Closed | -$19.5K | – | 673 |
|
|
2024
Q1 | $19.5K | Hold |
1,114
| – | – | ﹤0.01% | 1879 |
|
|
2023
Q4 | $10.5K | Hold |
1,114
| – | – | ﹤0.01% | 2164 |
|
|
2023
Q3 | $12.4K | Hold |
1,114
| – | – | ﹤0.01% | 2125 |
|
|
2023
Q2 | $23.8K | Hold |
1,114
| – | – | ﹤0.01% | 1837 |
|
|
2023
Q1 | $45.1K | Sell |
1,114
-159
| -12% | -$6.43K | ﹤0.01% | 1442 |
|
|
2022
Q4 | $59.2K | Hold |
1,273
| – | – | ﹤0.01% | 1361 |
|
|
2022
Q3 | $66K | Hold |
1,273
| – | – | ﹤0.01% | 1275 |
|
|
2022
Q2 | $60.2K | Hold |
1,273
| – | – | ﹤0.01% | 1381 |
|
|
2022
Q1 | $90.6K | Sell |
1,273
-4,139
| -76% | -$295K | ﹤0.01% | 1257 |
|
|
2021
Q4 | $405K | Hold |
5,412
| – | – | 0.01% | 1562 |
|
|
2021
Q3 | $307K | Buy |
5,412
+100
| +2% | +$5.68K | ﹤0.01% | 1754 |
|
|
2021
Q2 | $234K | Sell |
5,312
-1
| -0% | -$44 | ﹤0.01% | 2034 |
|
|
2021
Q1 | $262K | Hold |
5,313
| – | – | ﹤0.01% | 1829 |
|
|
2020
Q4 | $224K | Hold |
5,313
| – | – | ﹤0.01% | 1865 |
|
|
2020
Q3 | $243K | Sell |
5,313
-1,262
| -19% | -$57.8K | ﹤0.01% | 1661 |
|
|
2020
Q2 | $330K | Buy |
6,575
+893
| +16% | +$44.8K | 0.01% | 1488 |
|
|
2020
Q1 | $292K | Buy |
5,682
+208
| +4% | +$10.7K | 0.01% | 1369 |
|
|
2019
Q4 | $338K | Hold |
5,474
| – | – | 0.01% | 1564 |
|
|
2019
Q3 | $329K | Hold |
5,474
| – | – | 0.01% | 1547 |
|
|
2019
Q2 | $462K | Hold |
5,474
| – | – | 0.01% | 1354 |
|
|
2019
Q1 | $523K | Hold |
5,474
| – | – | 0.01% | 1267 |
|
|
2018
Q4 | $388K | Hold |
5,474
| – | – | 0.01% | 1365 |
|
|
2018
Q3 | $468K | Hold |
5,474
| – | – | 0.01% | 1422 |
|
|
2018
Q2 | $634K | Buy |
5,474
+472
| +9% | +$54.7K | 0.01% | 1159 |
|
|
2018
Q1 | $405K | Hold |
5,002
| – | – | 0.01% | 1414 |
|
|
2017
Q4 | $294K | Sell |
5,002
-5,640
| -53% | -$331K | ﹤0.01% | 1634 |
|
|
2017
Q3 | $498K | Sell |
10,642
-1,018
| -9% | -$47.6K | ﹤0.01% | 1693 |
|
|
2017
Q2 | $420K | Hold |
11,660
| – | – | ﹤0.01% | 1829 |
|
|
2017
Q1 | $359K | Hold |
11,660
| – | – | ﹤0.01% | 1883 |
|
|
2016
Q4 | $391K | Hold |
11,660
| – | – | ﹤0.01% | 1892 |
|
|
2016
Q3 | $310K | Hold |
11,660
| – | – | ﹤0.01% | 2046 |
|
|
2016
Q2 | $257K | Hold |
11,660
| – | – | ﹤0.01% | 2146 |
|
|
2016
Q1 | $342K | Hold |
11,660
| – | – | ﹤0.01% | 1816 |
|
|
2015
Q4 | $385K | Hold |
11,660
| – | – | ﹤0.01% | 1802 |
|
|
2015
Q3 | $421K | Buy |
11,660
+335
| +3% | +$12.1K | ﹤0.01% | 1750 |
|
|
2015
Q2 | $510K | Buy |
11,325
+3,103
| +38% | +$140K | ﹤0.01% | 1730 |
|
|
2015
Q1 | $252K | Hold |
8,222
| – | – | ﹤0.01% | 1932 |
|
|
2014
Q4 | $418K | Hold |
8,222
| – | – | ﹤0.01% | 1894 |
|
|
2014
Q3 | $325K | Hold |
8,222
| – | – | ﹤0.01% | 2016 |
|
|
2014
Q2 | $354K | Buy |
+8,222
| New | +$354K | ﹤0.01% | 2074 |
|